# Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Study · id `cardio:ct-nct04702451` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04702451](<https://clinicaltrials.gov/study/NCT04702451>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04702451

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 377 participants.

## Technical summary

Registry record NCT04702451. Randomized; double masking; primary purpose treatment. Start 2021-02-12 (actual); primary completion 2023-12-27 (actual). Results posted on 2025-09-12.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 377 participants (enrolled count; ClinicalTrials.gov record NCT04702451, source copy `cardio:ctgov-nct04702451-2025-09-12`, retrieved 2026-10-26)
- Started: 2021-02-12 (actual) (ClinicalTrials.gov record NCT04702451, source copy `cardio:ctgov-nct04702451-2025-09-12`, retrieved 2026-10-26)
- Primary completion: 2023-12-27 (actual) (ClinicalTrials.gov record NCT04702451, source copy `cardio:ctgov-nct04702451-2025-09-12`, retrieved 2026-10-26)
- Completion: 2023-12-27 (actual) (ClinicalTrials.gov record NCT04702451, source copy `cardio:ctgov-nct04702451-2025-09-12`, retrieved 2026-10-26)
- Results first posted: 2025-09-12 (ClinicalTrials.gov record NCT04702451, source copy `cardio:ctgov-nct04702451-2025-09-12`, retrieved 2026-10-26)
- Countries: United States; Belgium; France; Germany; Netherlands (ClinicalTrials.gov record NCT04702451, source copy `cardio:ctgov-nct04702451-2025-09-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04702451-2025-09-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
- Acronym: Tailored-AF
- Condition: Atrial Fibrillation
- Intervention (Procedure): Dispersion ablation + PVI
- Intervention (Device): VX1
- Intervention (Procedure): PVI
- Lead sponsor: Volta Medical
- Lead sponsor class: INDUSTRY
- Collaborator: Fortrea
- Collaborator class: INDUSTRY
- Collaborator: CardiaBase
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as a collaborator: Fortrea (`cardio:org-fortrea`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial (`cardio:pubmed-39953289`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial (`cardio:pubmed-41311304`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ac8fde3b4a4cd590a9c082abfa79e5be807dc2d80a157fee57110da032c1860d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
